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Background: Infection with Penicillium marneffei is a common opportunistic infection in Southeast Asia where it is
endemic. We report a case of Penicillium marneffei infection with fatal outcome in a Togolese woman infected with
Human Immunodeficiency Virus (HIV).
Case presentation: A 45-years-old patient, infected with Human Immunodeficiency Virus had consulted for ongoing
febrile pneumonia since two weeks. Clinical examination revealed fever of 38.5°C, dyspnea, pulmonary syndrome
condensation and papulo-nodular of “molluscum contagiosum” like lesions located on the face, arms, neck and trunk.
Sputum smear was negative for tuberculosis. The chest radiograph showed reticulonodular opacities in the right upper
and middle lobes and two caves in the right hilar region. The CD4 count was 6 cells/mm3 after a year of antiretroviral
treatment (Zidovudine-Lamivudine-Efavirenz). She was treated as smear negative pulmonary tuberculosis after a lack of
gentamicin and amoxicillin plus clavulanic acid response. Culture of skin samples and sputum had revealed the
presence of P. marneffei. A treatment with ketoconazole 600 mg per day was initiated. After two weeks of
treatment, there was a decrease in the size and number of papules and nodules, without any new lesions. We
noted disappearance of cough and fever. The chest X-ray showed a decrease of pulmonary lesions. There was no
reactivation of P. marneffei infection but the patient died from AIDS after two years of follow up.
Conclusion: We report a case of P. marneffei infection in a HIV-infected patient in a non-endemic country. Clinicians
should think of P. marneffei infection in all HIV-infected patients with “molluscum contagiosum” like lesions.
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Infection with P. marneffei is an opportunistic infection
occurring in immuno compromised patients [1]. It is en-
demic in South Asia and South-east Asia, where infec-
tion with P. marneffei ranks third behind tuberculosis
and cryptococcosis in Thailand, and behind Pneumocystis
carinii pneumonia (PCP) and pulmonary tuberculosis in
Hong Kong among Human Immunodeficiency Virus
(HIV) positive patients [2-4]. P. marneffei infection has* Correspondence: mlandoh@yahoo.fr
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non-endemic areas and who have stayed in endemic areas
[5,6]. We report a case of infection with P. marneffei with
fatal outcome in a Togolese woman infected with HIV at
the clinical World Health Organization (WHO) stage III
of acquired immunodeficiency syndrome (AIDS).Case presentation
A 45-year-old woman had consulted on 7th July 2008 in
the Department of Infectious Diseases and Pneumology of
the teaching hospital “Centre Hospitalier Universitaire”
(CHU) Sylvanus Olympio in Lomé for ongoing fever,Ltd. This is an open access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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was known to be HIV positive and was taking antiretro-
viral treatment (Zidovudine-Lamivudine-Efavirenz) as-
sociated with cotrimoxazole since July 2007. The CD4
count was 12 cells/mm3 at the beginning of antiretro-
viral treatment. She has always lived in Togo and has
never traveled outside the country. The clinical examin-
ation of the patient revealed a poor general condition
and nutritional status, a body temperature of 38.5°C, re-
spiratory rate of 48 breaths/min, a pulse at 78 beats/mi-
nute and blood pressure at 110/70 mm Hg. We noted a
thrush and a scar of the right intercostal zona. On the
face of the patient, we noted translucent papular and
nodular “molluscum contagiosum like” lesion with a small
central depression (Figure 1).
There was also a syndrome of pulmonary consolida-
tion characterized by increased vocal vibrations at the
right lung, dullness at the base of right lung crackling
rales at both lung bases.
Chest radiography showed reticulonodular opacities in
upper and middle right lobes and two caves in the right
hilar region. The CD4 count was 6 cells/mm3, the
hemoglobin rate was 10 g/dl and the leukocytes count
was 2 × 103 cells/μl. Smear was negative.
The patient was treated as bacterial pneumonia by the
combination of amoxicillin-clavulanic acid and gentamicin
for ten days without success, then as smear negative
pulmonary tuberculosis with two months combination
of (rifampicin + isoniazid + pyrazinamide + ethambutol)Figure 1 Papulo-nodular lesions “molluscum contagiosum” like
on the face of the patient.followed by four months combination of (rifampicin +
isoniazid) protocol.
Fungal culture of skin scraping and sputum sample on
Sabouraud medium with chloramphenicol without cy-
cloheximide, revealed fluffy colonies with a red appear-
ance grows after two weeks (Figure 2). Microscopic
examination revealed hyaline filamentous forms with
branches, sometimes with chains of smooth conidia giving
the appearance of a brush compatible with P. marneffei
(Figure 3).
A treatment with ketoconazole 600 mg per day was ini-
tiated. After two weeks of treatment, there was a decrease
in the size and number of papules and nodules, without
any new skin lesions. We noted disappearance of cough
and fever. The chest X-ray showed a decrease of pulmon-
ary lesions. There was no reactivation of P. marneffei
infection but the patient died from AIDS after two years
of follow up since his first consultation in the department
of infectious diseases.
Discussion
Penicillium marneffei infection has been reported as an
endemic disease in patients with immunodeficiency in
Thailand, China, Vietnam, Taiwan, Singapore and India.
The first reported case in West Africa occurred in a
HIV positive patient originated from Ghana who had
never traveled to tropical Asia [7]. Besides this case,
several cases were reported among Africans who have
traveled or resided in endemic countries [8-11]. In our
opinion, the first case reported here in Togo and the
case reported in Yo (Ghana) describe for the first time
this infection in West Africa, an area that is far from
the geographic reservoir. The natural reservoir, mode
of transmission and the natural history of infection
with P. marneffei are not clearly defined so far and re-
main research topics. The only known natural hosts
are the bamboo rats (Rhizomys and Cannomys spp.)
and humans [12]. P. marneffei can be isolated from soil
and rarely from other environmental sources. Activities
during the rainy season are also cited to be associated with
the risk of exposure in endemic countries [13]. It is be-
lieved that humans are infected by inhaling infectious
agent and rarely by direct animal contact. Inhaled spores
are phagocytosed by pulmonary histiocytes that are
disseminated in the body of the host and can cause a
systemic infection. Person to person transmission of
P. marneffei infection is not described nowadays.
The appearance of this infection in a Togolese patient
remains enigmatic. Unfortunately, the epidemiological
case investigation has not been made. But in 2000, the
description of P. marneffei infection in a patient originat-
ing from Ghana which shares border with Togo may infer
the existence of this fungal pathogen in these two coun-
tries. The development of maritime trade with the arrival
Tube 2: Culture of skin 
lesion showing red 
pigmentation after 2 weeks
Tube 3: Culture of skin 
lesion after 5 days
Tube 1: Culture of skin 
lesion without pigmentation 
after 72 hours
Figure 2 Red pigmentation after culture of skin lesion on Sabouraud medium without cycloheximide at 30° celsius.
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ways of transmission and “colonization” of these coasts by
the fungal.
The clinical features of penicilliosis are diverse and
multifaceted and constitute a challenge in term of diag-
nostic for clinicians. The clinical outcome of penicilliosis
can be fatal if it is not treated. Among the HIV-infected
patients naive of antiretroviral therapy, penicilliosis is a
sign of severe and late stage of HIV infection [12,14].
Our patient has immuno-clinical antiretroviral therapy
failure (CD4 count 6 cells/mm3) corresponding to severe
immunodeficiency. The patient has presented non-specificSmooth conidia giving the appearance of a 
brush compatible with Penicillium marneffei
Figure 3 Aspect of Penicillium marneffei at the microscopy
observation.symptoms such as fever, anemia, productive cough and
deterioration in general condition. These symptoms may
reveal bacterial pneumonia or lung’s tuberculosis. These
non-specific clinical signs and symptoms have justified
the treatment with beta-lactam antibiotic associated
with gentamicin and antituberculosis drugs. The evolu-
tion under this treatment was not favorable after two
months. Moreover, the pulmonary manifestations of
bacterial pneumonia do not associate skin lesion like
molluscum contagiosum as found in the patient. Cutane-
ous manifestations features described in penicilliosis are
translucent papular lesions, umbilicated with a central
necrotic depression [13-16], similar to those presented by
our patient on the face and trunk. These cutaneous mani-
festations are similar to skin lesions of cryptococcosis,
histoplasmosis or molluscum contagiosum. However, the
occurrence of these skin lesions in the context of fever,
cough, dyspnea, weight lost and fatigue made us suggest
infection with P. marneffei although the patient had always
lived in Togo on the basis of a lack of clinical response to
antibiotic treatment and culture on Sabouraud’s medium
revealing a red pigment (Figure 2).
According to studies, culture from bone marrow,
blood and skin samples are positive respectively at
100%, 76% and 90% of cases [13,17-20]. The identifica-
tion of P. marneffei is based on the characteristics of its
colony and microscopic morphology [16], with filament-
ous branches, sometimes with smooth conidia (Figure 3).
The first description of this disease was made in a patient
with Hodgkin’s lymphoma in Southeast Asia [7]. Before
the first description of the disease in a HIV-infected
patient in 1988 [8], penicilliosis was uncommon, with
less than 40 cases reported [9,10].
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ketoconazole, voriconazole, miconazole, terbinafine and
5-fluorocytosine, amphotericin B, and less sensitive to
fluconazole. The recommended treatment in penicilliosis
is amphotericin B through intravenous route at a dose of
0.6 mg/kg per day for two weeks followed by 10 weeks of
secondary prophylaxis with itraconazole (400 mg/day)
[13,18]. Ketoconazole orally at a dose of 600 mg a day
was the available treatment to our patient in all phases.
This treatment was combined with highly active anti-
retroviral therapy. (Tenofovir/Lamivudine and boosted
by Lopinavir).
This second case in West Africa raises the problem of
fungus’ reservoir and the route of its transmission.Conclusion
Our observation reports a case of P. marneffei infection
with fatal outcome in a patient infected with HIV in a
non-endemic country. It invites clinicians to think of an
infection with P. marneffei in all HIV-infected patients
with lesions of molluscum contagiosum because only early
diagnosis and proper treatment leads to a reduction in
mortality associated with this disease.Consent
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